Joshua Courtright
Children's Hospital of Philadelphia(US)Cancer Research Institute(US)Children's Cancer Institute Australia(AU)GlaxoSmithKline (United States)(US)Sydney Children's Hospital(AU)University of Pennsylvania(US)
Publications by Year
Research Areas
Neuroblastoma Research and Treatments, Protein Degradation and Inhibitors, Lung Cancer Treatments and Mutations, Cancer therapeutics and mechanisms, Cancer-related gene regulation
Most-Cited Works
- → The pediatric preclinical testing program: Description of models and early testing results(2006)482 cited
- → Differential Inhibitor Sensitivity of Anaplastic Lymphoma Kinase Variants Found in Neuroblastoma(2011)230 cited
- → Initial testing of the VEGFR inhibitor AZD2171 by the pediatric preclinical testing program(2007)116 cited
- → Initial testing (stage 1) of sunitinib by the pediatric preclinical testing program(2008)85 cited
- → Serial Transcriptome Analysis and Cross-Species Integration Identifies Centromere-Associated Protein E as a Novel Neuroblastoma Target(2010)53 cited
- Pediatric preclinical testing program (PPTP) evaluation of the EGFR and ErbB2 inhibitor lapatinib(2007)
- Pediatric preclinical testing program (PPTP) evaluation of the MEK1/2 inhibitor AZD6244 (ARRY-142886)(2008)